Poor air quality from wildfires may have an impact on mental health; a new executive order to lower prescription drug prices; Pfizer and BioNTech will expand the phase 3 trial of their COVID-19 vaccine.
As wildfires on the West Coast continue to cause record-breaking poor air quality in states such as California and Oregon, a San Francisco psychologist suggested a link with increased feelings of isolation and depression. Reported by ABC7 San Francisco, fires and the resulting smoke, as well as the coronavirus disease 2019 (COVID-19) have caused residents to stay inside to avoid risk of pollution and infection. Due to increased levels of pollution and the potential of seasonal affective disorder, a doctor of clinical psychology noted an increase in patients reporting headaches and signs of depression.
Yesterday, President Donald Trump signed a new executive order that he touts will lower prescription drug prices, but experts say that the move is unlikely to provide any immediate impact. Reported by NPR, the executive order repeals an executive order from 2 months ago that Trump announced but did not release to negotiate a better deal with drug companies. The new executive order will expand the drugs covered by Trump’s proposed “most favored nations” pricing scheme, which will include both Medicare Part B and Medicare Part D beneficiaries.
Reported by STAT, Pfizer and BioNTech announced they will expand the phase 3 trial of their COVID-19 vaccine by 50%, totaling to 44,000 participants. The move, which will increase data on safety and efficacy, will also promote a more diverse population that will include adolescents as young as 16, people with stable HIV, and people with hepatitis C or B. However, it was noted that the Pfizer, BioNTech vaccine could prove to be the most difficult of the experimental vaccines to distribute if proven effective as it must be kept at a temperature of –70 degrees celsius.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Early Involvement Critical in Treating Immunotherapy-Induced Overlap Syndrome
April 19th 2024A series of case studies reveals the importance of early diagnosis and involvement of special teams of clinicians when dealing with potential cases of overlap syndrome, which encompasses myocarditis, myasthenia gravis, and immune checkpoint inhibitor–related myositis.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen